391 related articles for article (PubMed ID: 28473042)
1. Monoclonal Gammopathy-Associated Peripheral Neuropathy: Diagnosis and Management.
Chaudhry HM; Mauermann ML; Rajkumar SV
Mayo Clin Proc; 2017 May; 92(5):838-850. PubMed ID: 28473042
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy and neuropathy.
Ramchandren S; Lewis RA
Curr Opin Neurol; 2009 Oct; 22(5):480-5. PubMed ID: 19625962
[TBL] [Abstract][Full Text] [Related]
3. [Neurological manifestations of monoclonal gammopathies].
Chassande B; Léger JM
Rev Prat; 1993 Feb; 43(3):314-6. PubMed ID: 8389055
[TBL] [Abstract][Full Text] [Related]
4. Peripheral neuropathy with gammopathy responding to plasmapheresis.
Frayne J; Stark RJ
Clin Exp Neurol; 1985; 21():195-200. PubMed ID: 3032483
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy and neuropathy.
Lozeron P; Adams D
Curr Opin Neurol; 2007 Oct; 20(5):536-41. PubMed ID: 17885441
[TBL] [Abstract][Full Text] [Related]
6. Selective techniques of apheresis in polyneuropathy associated with monoclonal gammopathy of undetermined significance.
Siciliano G; Moriconi L; Gianni G; Richieri E; Vignocchi MG; Rossi B
Acta Neurol Scand; 1994 Feb; 89(2):117-22. PubMed ID: 8191874
[TBL] [Abstract][Full Text] [Related]
7. Investigation and Management of Immunoglobulin M- and Waldenström-Associated Peripheral Neuropathies.
Tomkins O; Leblond V; Lunn MP; Viala K; Weil DR; D'Sa S
Hematol Oncol Clin North Am; 2023 Aug; 37(4):761-776. PubMed ID: 37385714
[TBL] [Abstract][Full Text] [Related]
8. Polyneuropathy in paraproteinaemia.
Meier C
J Neurol; 1985; 232(4):204-14. PubMed ID: 2995596
[TBL] [Abstract][Full Text] [Related]
9. Peripheral Neuropathies Associated With Monoclonal Gammopathies.
Naddaf E; Mauermann ML
Continuum (Minneap Minn); 2020 Oct; 26(5):1369-1383. PubMed ID: 33003006
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal gammopathies of undetermined significance.
Kyle RA; Rajkumar SV
Rev Clin Exp Hematol; 2002 Sep; 6(3):225-52. PubMed ID: 12616697
[TBL] [Abstract][Full Text] [Related]
11. Kappa light chain restriction correlates with peripheral neuropathy in patients with non-IgM monoclonal gammopathy of undetermined significance.
Dasanu CA; Kaur J; Farrell S; Plaxe SC
Eur J Haematol; 2022 Jan; 108(1):86-87. PubMed ID: 34624145
[No Abstract] [Full Text] [Related]
12. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
Haematologica; 2012 Jun; 97(6):854-8. PubMed ID: 22180421
[TBL] [Abstract][Full Text] [Related]
13. [Peripheral neuropathies associated with monoclonal gammapathies. Value of electrophysiologic studies].
Bouche P; Bouchacourt E; Leger JM; Travers MA; Cathala HP
Rev Electroencephalogr Neurophysiol Clin; 1985 Dec; 15(3):255-65. PubMed ID: 3006187
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathies associated with monoclonal proteins: a clinical review.
Kelly JJ
Muscle Nerve; 1985 Feb; 8(2):138-50. PubMed ID: 2997604
[TBL] [Abstract][Full Text] [Related]
15. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
16. Are neurological complications of monoclonal gammopathy of undetermined significance underestimated?
Steiner N; Schwärzler A; Göbel G; Löscher W; Wanschitz J; Gunsilius E
Oncotarget; 2017 Jan; 8(3):5081-5091. PubMed ID: 27974705
[TBL] [Abstract][Full Text] [Related]
17. [Successful treatment with rituximab in two cases of IgM-monoclonal gammopathy of undetermined significance (MGUS) neuropathy].
Koike M; Sugimoto K; Tusui M; Yahata Y
Rinsho Ketsueki; 2012 Apr; 53(4):450-4. PubMed ID: 22687979
[TBL] [Abstract][Full Text] [Related]
18. IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.
Campagnolo M; Zambello R; Nobile-Orazio E; Benedetti L; Marfia GA; Riva N; Castellani F; Bianco M; Salvalaggio A; Garnero M; Ruiz M; Mataluni G; Fazio R; Ermani M; Briani C
J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1094-1097. PubMed ID: 28501820
[No Abstract] [Full Text] [Related]
19. An update on monoclonal gammopathy and neuropathy.
Ramchandren S; Lewis RA
Curr Neurol Neurosci Rep; 2012 Feb; 12(1):102-10. PubMed ID: 22090258
[TBL] [Abstract][Full Text] [Related]
20. Autologous peripheral blood stem cell transplantation for peripheral neuropathy secondary to monoclonal gammopathy of unknown significance.
Lee YC; Came N; Schwarer A; Day B
Bone Marrow Transplant; 2002 Jul; 30(1):53-6. PubMed ID: 12105779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
